Bio Essence Corporation
BIOE
$0.206
-$0.008-3.74%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 85.75% | -281.04% | -7.38% | 174.89% | 9.15% |
| Total Depreciation and Amortization | 100.99% | -99.39% | -98.15% | -80.00% | -30.60% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -75.00% | 1,853.65% | 84.19% | -532.93% | -51.55% |
| Change in Net Operating Assets | 1,122.82% | 397.71% | 211.94% | -223.61% | -94.06% |
| Cash from Operations | 307.30% | 203.57% | 106.24% | 25.94% | -57.97% |
| Capital Expenditure | -- | -- | -- | -- | -100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 99.89% | -- | -- | -- | -1,498.18% |
| Total Debt Issued | -- | -155.55% | -101.84% | -11.88% | 69.38% |
| Total Debt Repaid | -1,278.85% | -1,138.36% | 99.44% | -3,133.33% | 219.17% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | -- | -- | -197.89% | -- |
| Cash from Financing | -254.62% | -196.78% | -102.36% | -23.94% | 107.83% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -28,700.00% | 4,160.00% | 2,275.00% | 100.00% | -98.25% |